96 related articles for article (PubMed ID: 16815286)
1. Systemic absorption of 5-fluorouracil during vitrectomy.
Creten O; Spileers W; Stalmans P
Am J Ophthalmol; 2006 Jul; 142(1):194-6. PubMed ID: 16815286
[TBL] [Abstract][Full Text] [Related]
2. Systemic resorption of 5-fluorouracil used in infusion fluid during vitrectomy.
Creten O; Spileers W; Stalmans P
Bull Soc Belge Ophtalmol; 2007; (303):37-41. PubMed ID: 17894285
[TBL] [Abstract][Full Text] [Related]
3. Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. Determination of alpha-fluoro-beta-alanine in urine.
Sessink PJ; Timmersmans JL; Anzion RB; Bos RP
J Occup Med; 1994 Jan; 36(1):79-83. PubMed ID: 8138854
[TBL] [Abstract][Full Text] [Related]
4. Assay of urinary alpha-fluoro-beta-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians.
Rubino FM; Verduci C; Buratti M; Fustinoni S; Campo L; Omodeo-Salè E; Giglio M; Iavicoli S; Brambilla G; Colombi A
Biomed Chromatogr; 2006 Mar; 20(3):257-66. PubMed ID: 16167301
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
Wickham L; Bunce C; Wong D; McGurn D; Charteris DG
Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
[TBL] [Abstract][Full Text] [Related]
6. Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil.
Thiberville L; Compagnon P; Moore N; Bastian G; Richard MO; Hellot MF; Vincent C; Kannass MM; Dominique S; Thuillez C
Cancer Chemother Pharmacol; 1994; 35(1):64-70. PubMed ID: 7987979
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy].
Bi HS; Cui Y; Zhang JH; Wang XR; Xie XF
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):37-41. PubMed ID: 16638279
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs.
Schmidt Laugesen C; Steffansen B; Scherfig E; la Cour M
Acta Ophthalmol Scand; 2005 Apr; 83(2):184-90. PubMed ID: 15799730
[TBL] [Abstract][Full Text] [Related]
9. Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Ozaki Y; Imamaki H; Ikeda A; Oura M; Nakagawa S; Funakoshi T; Kataoka S; Nishikawa Y; Horimatsu T; Yonezawa A; Matsubara T; Yanagita M; Muto M; Watanabe N
Cancer Chemother Pharmacol; 2020 Nov; 86(5):693-699. PubMed ID: 33011861
[TBL] [Abstract][Full Text] [Related]
10. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
11. Decreased vitreal hyaluronan levels with aging.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
[TBL] [Abstract][Full Text] [Related]
12. Vitreous proteomic analysis of proliferative vitreoretinopathy.
Yu J; Liu F; Cui SJ; Liu Y; Song ZY; Cao H; Chen FE; Wang WJ; Sun T; Wang F
Proteomics; 2008 Sep; 8(17):3667-78. PubMed ID: 18752205
[TBL] [Abstract][Full Text] [Related]
13. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention.
Shimada H; Nakashizuka H; Hattori T; Mori R; Mizutani Y; Yuzawa M
Ophthalmology; 2008 Dec; 115(12):2215-20. PubMed ID: 18930557
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.
Quiram PA; Gonzales CR; Hu W; Gupta A; Yoshizumi MO; Kreiger AE; Schwartz SD
Ophthalmology; 2006 Nov; 113(11):2041-7. PubMed ID: 16952397
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.
Zheng H; Wang Z; Wang P; Liu Y; Jiang Z; Gao Q
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):751-9. PubMed ID: 22119880
[TBL] [Abstract][Full Text] [Related]
17. Biomonitoring of occupational exposure to 5-FU by assaying α-fluoro-β-alanine in urine with a highly sensitive UHPLC-MS/MS method.
Dhersin A; Atgé B; Martinez B; Titier K; Rousset M; Sidatt Cheikh El Moustaph M; Verdun-Esquer C; Molimard M; Villa A; Canal-Raffin M
Analyst; 2018 Aug; 143(17):4110-4117. PubMed ID: 30058665
[TBL] [Abstract][Full Text] [Related]
18. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
19. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.
Banerjee S; Savant V; Scott RA; Curnow SJ; Wallace GR; Murray PI
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2203-7. PubMed ID: 17460280
[TBL] [Abstract][Full Text] [Related]
20. [Advantages and disadvantages of the circumferential retinal cryocoagulation before vitrectomy in proliferative diabetic vitreoretinopathy].
Schulze S; Zaki N; Kroll P
Klin Monbl Augenheilkd; 2007 Aug; 224(8):647-52. PubMed ID: 17717781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
